Acorda Therapeutics Inc (NASDAQ:ACOR)

32.01
Delayed Data
As of May 22
 -0.25 / -0.77%
Today’s Change
28.26
Today|||52-Week Range
45.45
-21.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues97.1M106.0M117.9M99.9M
 
 
 
 
 
Cost of Goods Sold17.2M19.0M22.0M18.6M
 
 
 
 
 
Depreciation And Amortization1.9M1.8M3.1M--
 
 
 
 
 
Operating ExpensesGross Income78.1M85.2M92.7M81.2M
 
 
 
 
 
General Expenses67.1M62.2M77.8M79.4M
 
 
 
 
 
Research And Development16.4M16.6M25.9M30.6M
 
 
 
 
 
Total Operating Expenses86.1M82.9M103.0M98.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income11.0M23.1M14.9M1.8M
 
 
 
 
 
Extraordinary Credit0.00--263.0K--
 
 
Extraordinary Charge-9.0K-2.4M-14.0M-3.1M
 
 
 
 
 
Interest Expense On Debt426.0K4.6M4.2M--
 
 
 
 
Other Expenses0.00167.0K0.00-3.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.7M16.5M-2.7M-5.1M
 
 
 
 
 
Income Taxes-6.0M-4.5M-3.0M-2.0M
 
 
 
 
 
Net Income4.7M12.0M330.0K-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.0M41.1M41.5M42.0M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M42.4M43.1M42.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.11$0.28$0.01-$0.07
 
 
 
 
 
EPS Diluted$0.11$0.28$0.01-$0.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account